Viewing Study NCT05288205

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 3:26 AM

Ignite Modification Date: 2025-12-26 @ 2:06 AM

Study NCT ID: NCT05288205

Status: RECRUITING

Last Update Posted: 2025-04-04

First Post: 2022-03-11

Is NOT Gene Therapy: False

Has Adverse Events: False

Brief Title: Phase 1/2a Study of JAB-21822 Plus JAB-3312 in Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation

Sponsor: Allist Pharmaceuticals, Inc.

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module